NCT01104194

Brief Summary

The investigators recently found a positive effect of omega-3 supplements on cognitive function in healthy individuals after 4 weeks (J of Psychopharmacology 2009, 23: 831-840). The investigators hypothesize that 4 weeks consumption of omega-3 supplements in previously depressed individuals will positively affect their cognitive functions. Secondly, low Heart Rate Variability (HRV) is a risk factor for cardiovascular disease. Some studies have found low HRV in patients with depression. No studies have investigated the effects of omega-3 fatty acid supplements on Heart Rate Variability in individuals with a history of depression. The investigators will test the hypotheses that omega-3 supplements lead to an improvement of heart rate variability indices in healthy volunteers with a history of depression.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Sep 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

April 12, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 15, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
Last Updated

July 11, 2011

Status Verified

July 1, 2011

Enrollment Period

2 years

First QC Date

April 12, 2010

Last Update Submit

July 8, 2011

Conditions

Keywords

depressioncognitionheart rate variabilityomega-3 fatty acidsDepression (in remission) (vulnerability to depression)

Outcome Measures

Primary Outcomes (2)

  • Cognition

    Battery of test measuring emotional and neutral information processing. Largest effect expected on Decision Making Test (cf. Antypa et al., 2009) and Emotion Recognition Test.

    4 weeks

  • Heart Rate Variability

    4 weeks

Secondary Outcomes (1)

  • Mood states

    4 weeks

Study Arms (2)

Fish-oil

EXPERIMENTAL
Dietary Supplement: omega-3 fatty acids supplements (fish oil)

Placebo

PLACEBO COMPARATOR

Olive oil capsules, identical in appearance to fish oil capsules

Dietary Supplement: Placebo

Interventions

1.74g eicosapentaenoic acid (EPA) and 0.25g docosahexaenoic acid (DHA)

Fish-oil
PlaceboDIETARY_SUPPLEMENT

softgel capsules (identical in appearance to fish oil capsules) containing olive oil. 3 capsules/day, 4 weeks

Placebo

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Dutch-speaking men and women
  • Normal weight (BMI between 18 and 27).
  • Regular diets, not containing fish more than once a week.
  • History of depression (at least one major depressive episode in the past).

You may not qualify if:

  • Currently more than mildly depressed (BDI-II-NL score higher than 19, or score on the suicidality item of this scale higher than 1).
  • Current or past psychosis
  • Current substance abuse or past substance dependence
  • Smoking or current use of soft drugs (current = month prior to study till completion)
  • Any hard drug use (lifetime)
  • More than 3 alcoholic consumptions/day
  • Participants will be asked to keep their dietary habits constant throughout the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leiden University

Leiden, South Holland, 2333 AK, Netherlands

Location

MeSH Terms

Conditions

Depression

Interventions

Fish Oils

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

OilsLipids

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

April 12, 2010

First Posted

April 15, 2010

Study Start

September 1, 2008

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

July 11, 2011

Record last verified: 2011-07

Locations